We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SO icon
201
Southern Company
SO
$99.1B
$4.35M 0.08%
60,962
+19,903
+48% +$1.33M
2022 Q3
1 quarter
DOW icon
202
Dow Inc
DOW
$20.5B
$4.34M 0.08%
+86,207
New +$4.21M
2022 Q4
0 quarters
BMAC
203
DELISTED
Black Mountain Acquisition Corp.
BMAC
$4.34M 0.08%
425,359
-4,162
-1% -$42K
2022 Q2
2 quarters
DOC icon
204
Healthpeak Properties
DOC
$13B
$4.32M 0.08%
172,107
+81,096
+89% +$1.97M
2022 Q1
3 quarters
COCH icon
205
Envoy Medical
COCH
$50.9M
$4.28M 0.08%
423,516
-4,144
-1% -$41.2K
2021 Q2
6 quarters
BRX icon
206
Brixmor Property Group
BRX
$8.38B
$4.26M 0.08%
+187,766
New +$4.02M
2022 Q4
0 quarters
AVTR icon
207
Avantor
AVTR
$10.6B
$4.24M 0.08%
200,889
-133,281
-40% -$2.76M
2022 Q1
3 quarters
CCK icon
208
Crown Holdings
CCK
$11.8B
$4.23M 0.08%
+51,467
New +$4.1M
2022 Q4
0 quarters
CC icon
209
Chemours
CC
$2.05B
$4.18M 0.08%
136,570
+24,449
+22% +$734K
2020 Q4
8 quarters
PDD icon
210
Pinduoduo
PDD
$116B
$4.18M 0.08%
51,281
+30,619
+148% +$2.13M
2022 Q3
1 quarter
PRPC
211
DELISTED
CC Neuberger Principal Holdings III
PRPC
$4.13M 0.08%
409,413
-4,022
-1% -$40.3K
2021 Q2
6 quarters
ALOR
212
DELISTED
ALSP Orchid Acquisition Corp I
ALOR
$4.13M 0.08%
401,729
-3,931
-1% -$39.9K
2022 Q1
3 quarters
VMGA
213
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
$4.1M 0.08%
401,729
-3,931
-1% -$39.6K
2022 Q1
3 quarters
JAZZ icon
214
Jazz Pharmaceuticals
JAZZ
$14.2B
$4.07M 0.08%
25,547
-33,493
-57% -$4.91M
2022 Q1
3 quarters
DISA
215
DELISTED
Disruptive Acquisition Corporation I Class A Ordinary Shares
DISA
$3.98M 0.07%
394,639
-3,862
-1% -$38.6K
2021 Q2
6 quarters
GSK icon
216
GSK
GSK
$93.2B
$3.96M 0.07%
112,777
-52,299
-32% -$1.74M
2022 Q3
1 quarter
CTAQ
217
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$3.96M 0.07%
386,583
-3,799
-1% -$38.2K
2021 Q1
7 quarters
FTEV
218
DELISTED
FinTech Evolution Acquisition Group
FTEV
$3.96M 0.07%
391,876
-3,834
-1% -$38.3K
2021 Q2
6 quarters
GVCI
219
DELISTED
Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares
GVCI
$3.92M 0.07%
378,097
-3,700
-1% -$37.9K
2022 Q1
3 quarters
STI icon
220
Solidion Technology
STI
$51.1M
$3.91M 0.07%
7,282
-71
-1% -$35.9K
2022 Q2
2 quarters
USCT icon
221
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
$3.9M 0.07%
378,097
-3,700
-1% -$37.9K
2022 Q1
3 quarters
ZCAR icon
222
DELISTED
Zoomcar
ZCAR
$3.89M 0.07%
189
-2
-1% -$40.8K
2022 Q1
3 quarters
SVNA
223
DELISTED
7 Acquisition Corp
SVNA
$3.89M 0.07%
378,097
-3,700
-1% -$37.6K
2022 Q1
3 quarters
IQMD
224
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$3.89M 0.07%
378,097
-3,700
-1% -$37.6K
2022 Q1
3 quarters
MAA icon
225
Mid-America Apartment Communities
MAA
$13.6B
$3.89M 0.07%
24,754
-13,151
-35% -$2.05M
2022 Q2
2 quarters

Similar funds

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.